Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns
NCT ID: NCT01697904
Last Updated: 2012-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2010-08-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Oxygen Strategy
Resuscitation was initiated with room air (21% O2) for LOX infants. Supplemental oxygen was given if 1) the heart rate (HR) was less than 100 bpm after 30 seconds of effective ventilation, 2) the lower limits of goal saturations were not met. Targeted goal Pre-ductal saturations after birth were derived by approximation of the interquartile values for healthy term infants as reported by Kamlin et al and Dawson et al.FiO2 was increased or decreased by 10% in 30 second intervals as needed. If HR \< 60 bpm after 30 seconds of effective ventilation , FiO2 was increased to 100% until the heart rate was stabilized.
Targeted Pre-ductal SpO2 After birth
1. min 60%-65%
2. min 65%-70%
3. min 70%-75%
4. min 75%-80%
5. min 80%-85%
10 min 85%-94%
Titration of oxygen during newborn resuscitation in delivery room
Traditional Oxygen strategy ( TOX)
Resuscitation for TOX infants was started with 100% O2 and adjusted every 30 seconds by 10% to meet the target oxygen saturation range of 85-94%
Titration of oxygen during newborn resuscitation in delivery room
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Titration of oxygen during newborn resuscitation in delivery room
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestation age 24 0/7 to 34 6/7
* Need for active resuscitation
Exclusion Criteria
* Non-viable newborns
* Precipitous delivery and resuscitation team not present in the delivery room to initiate resuscitation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vishal Kapadia
Assistant Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vishal S Kapadia, MD
Role: PRINCIPAL_INVESTIGATOR
UT Southwestern
Myra H Wyckoff, MD
Role: PRINCIPAL_INVESTIGATOR
UT Southwestern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkland Memorial Hospital
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kapadia VS, Chalak LF, Sparks JE, Allen JR, Savani RC, Wyckoff MH. Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics. 2013 Dec;132(6):e1488-96. doi: 10.1542/peds.2013-0978. Epub 2013 Nov 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU 052011-044
Identifier Type: -
Identifier Source: org_study_id